• Je něco špatně v tomto záznamu ?

The Digital Revolution in Medicine: Applications in Cardio-Oncology

G. Echefu, L. Batalik, A. Lukan, R. Shah, P. Nain, A. Guha, SA. Brown

. 2025 ; 27 (1) : . [pub] 20241105

Status neindexováno Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25001855

Grantová podpora
KL2 TR001438 NCATS NIH HHS - United States
UL1 TR001436 NCATS NIH HHS - United States

PURPOSE OF REVIEW: A critical evaluation of contemporary literature regarding the role of big data, artificial intelligence, and digital technologies in precision cardio-oncology care and survivorship, emphasizing innovative and groundbreaking endeavors. RECENT FINDINGS: Artificial intelligence (AI) algorithm models can automate the risk assessment process and augment current subjective clinical decision tools. AI, particularly machine learning (ML), can identify medically significant patterns in large data sets. Machine learning in cardio-oncology care has great potential in screening, diagnosis, monitoring, and managing cancer therapy-related cardiovascular complications. To this end, large-scale imaging data and clinical information are being leveraged in training efficient AI algorithms that may lead to effective clinical tools for caring for this vulnerable population. Telemedicine may benefit cardio-oncology patients by enhancing healthcare delivery through lowering costs, improving quality, and personalizing care. Similarly, the utilization of wearable biosensors and mobile health technology for remote monitoring holds the potential to improve cardio-oncology outcomes through early intervention and deeper clinical insight. Investigations are ongoing regarding the application of digital health tools such as telemedicine and remote monitoring devices in enhancing the functional status and recovery of cancer patients, particularly those with limited access to centralized services, by increasing physical activity levels and providing access to rehabilitation services. SUMMARY: In recent years, advances in cancer survival have increased the prevalence of patients experiencing cancer therapy-related cardiovascular complications. Traditional cardio-oncology risk categorization largely relies on basic clinical features and physician assessment, necessitating advancements in machine learning to create objective prediction models using diverse data sources. Healthcare disparities may be perpetuated through AI algorithms in digital health technologies. In turn, this may have a detrimental effect on minority populations by limiting resource allocation. Several AI-powered innovative health tools could be leveraged to bridge the digital divide and improve access to equitable care.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25001855
003      
CZ-PrNML
005      
20250123101936.0
007      
ta
008      
250117s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s11936-024-01059-x $2 doi
035    __
$a (PubMed)39610711
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Echefu, Gift $u Division of Cardiovascular Medicine, University of Tennessee, Memphis, TN
245    14
$a The Digital Revolution in Medicine: Applications in Cardio-Oncology / $c G. Echefu, L. Batalik, A. Lukan, R. Shah, P. Nain, A. Guha, SA. Brown
520    9_
$a PURPOSE OF REVIEW: A critical evaluation of contemporary literature regarding the role of big data, artificial intelligence, and digital technologies in precision cardio-oncology care and survivorship, emphasizing innovative and groundbreaking endeavors. RECENT FINDINGS: Artificial intelligence (AI) algorithm models can automate the risk assessment process and augment current subjective clinical decision tools. AI, particularly machine learning (ML), can identify medically significant patterns in large data sets. Machine learning in cardio-oncology care has great potential in screening, diagnosis, monitoring, and managing cancer therapy-related cardiovascular complications. To this end, large-scale imaging data and clinical information are being leveraged in training efficient AI algorithms that may lead to effective clinical tools for caring for this vulnerable population. Telemedicine may benefit cardio-oncology patients by enhancing healthcare delivery through lowering costs, improving quality, and personalizing care. Similarly, the utilization of wearable biosensors and mobile health technology for remote monitoring holds the potential to improve cardio-oncology outcomes through early intervention and deeper clinical insight. Investigations are ongoing regarding the application of digital health tools such as telemedicine and remote monitoring devices in enhancing the functional status and recovery of cancer patients, particularly those with limited access to centralized services, by increasing physical activity levels and providing access to rehabilitation services. SUMMARY: In recent years, advances in cancer survival have increased the prevalence of patients experiencing cancer therapy-related cardiovascular complications. Traditional cardio-oncology risk categorization largely relies on basic clinical features and physician assessment, necessitating advancements in machine learning to create objective prediction models using diverse data sources. Healthcare disparities may be perpetuated through AI algorithms in digital health technologies. In turn, this may have a detrimental effect on minority populations by limiting resource allocation. Several AI-powered innovative health tools could be leveraged to bridge the digital divide and improve access to equitable care.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Batalik, Ladislav $u Department of Rehabilitation, University Hospital Brno, Czech Republic $u Department of Physiotherapy and Rehabilitation, Masaryk University, Brno, Czech Republic
700    1_
$a Lukan, Abdulkareem $u Advocate Illinois Masonic Medical Center, Chicago, IL
700    1_
$a Shah, Rushabh $u Medical College of Wisconsin, Milwaukee, WI
700    1_
$a Nain, Priyanshu $u Division of Cardiology, Medical College of Georgia, Augusta, GA
700    1_
$a Guha, Avirup $u Division of Cardiology, Medical College of Georgia, Augusta, GA
700    1_
$a Brown, Sherry-Ann $u Department of Medicine, Medical College of Wisconsin, Milwaukee, WI $u Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN $u Heart Innovation and Equity Research (HIER) Group, Miami, FL
773    0_
$w MED00215990 $t Current treatment options in cardiovascular medicine $x 1092-8464 $g Roč. 27, č. 1 (2025)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39610711 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250117 $b ABA008
991    __
$a 20250123101930 $b ABA008
999    __
$a ok $b bmc $g 2254408 $s 1237858
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2025 $b 27 $c 1 $e 20241105 $i 1092-8464 $m Current treatment options in cardiovascular medicine $n Curr Treat Options Cardiovasc Med $x MED00215990
GRA    __
$a KL2 TR001438 $p NCATS NIH HHS $2 United States
GRA    __
$a UL1 TR001436 $p NCATS NIH HHS $2 United States
LZP    __
$a Pubmed-20250117

Najít záznam

Citační ukazatele

Možnosti archivace